China’s Q3 GDP came in well below market expectations at 4.9% year-on-year (y-o-y), compared to 18.3% in Q1 and 7.9% in Q2. Although exports continued to hold up strongly, other parts of the economy decelerated quite sharply in Q3 due to lingering...

Against the backdrop of broadening inflationary pressures, the European Central Bank (ECB) is on track to end its pandemic emergency purchase programme (PEPP) in March 2022. We forecast that PEPP purchases will be reduced to EUR50 bn per month in ...

The search for yield is prompting more and more investors to look beyond public markets and explore the world of illiquid asset classes. The low-interest-rate environment and uncertainty on interest rates bolster the appeal of alternative credit, ...

The Covid-19 pandemic has put the onus on health. Well-designed and well-serviced cities are a key piece of the puzzle. Smart cities aren’t just about robotics and futuristic design. To be truly smart, they also need to protect and promote the ...

The enormous progress in the development of medicines, especially vaccines, has made the pharmaceutical and biotech industries the focus of public and investor interest in the last two years. Especially the forward leaps in biotechnology, for exam...

Toby NangleToby Nangle, Co-Head of Global Asset Allocation & Head of Multi-Asset, EMEA After 18 months of exceptionally strong equity markets, most measures of valuations look high against their own absolute histories. The measure most favo...